NCT01127282

The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A

The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A: a Randomized-controlled Trial

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 180 (estimated)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Influenza continues to inflict an important burden on health-care systems. The 2009 H1N1 influenza virus first appeared in Mexico and the United States in March and April 2009 and has swept the globe with unprecedented speed. The aim of this study is to evaluate effect of supplement vitamin on the clinical course of patients with acute respiratory illness suspected novel H1N1 infection.

Detailed description

Patients with acute respiratory illness randomized to control or vitamin groups. The patients completed questionnaire about their initial symptom scores. After 5 days of vitamin trial, patients were asked about their symptom by telephone survey.

Conditions

• H1N1 Influenza

Interventions

Type	Name	Description
DRUG	Vitamin (vitamin A 15 mg,C 500 mg, E 400IU)	Vitamin (vitamin A 15 mg,C 500 mg, E 400IU) 1T po for 5 days in addition to anti-viral agent and antipyretics
DRUG	Placebo (digestive tablet)	Placebo (digestive tablet) 1T po for 5 days in addition to anti-viral agent and antipyretics

Timeline

• Start date: 2009-12-01
• Primary completion: 2010-06-01
• Completion: 2010-08-01
• First posted: 2010-05-20
• Last updated: 2010-05-20

Locations

1 site across 1 country: South Korea